Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laser Therapy | 14 | 1997 | 1071 | 0.820 |
Why?
|
| Paranasal Sinus Neoplasms | 5 | 1996 | 234 | 0.410 |
Why?
|
| Frontal Sinus | 2 | 1996 | 50 | 0.230 |
Why?
|
| Mouth Mucosa | 3 | 1997 | 434 | 0.220 |
Why?
|
| Palatal Neoplasms | 1 | 2002 | 35 | 0.220 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2002 | 68 | 0.210 |
Why?
|
| Cochlear Implants | 3 | 1996 | 339 | 0.200 |
Why?
|
| Otorhinolaryngologic Diseases | 2 | 1994 | 90 | 0.190 |
Why?
|
| Nose Neoplasms | 3 | 1993 | 245 | 0.190 |
Why?
|
| Ethmoid Sinus | 2 | 1996 | 58 | 0.170 |
Why?
|
| Petrous Bone | 2 | 1996 | 86 | 0.160 |
Why?
|
| Plethysmography, Whole Body | 2 | 1988 | 24 | 0.160 |
Why?
|
| Neurilemmoma | 2 | 1996 | 547 | 0.160 |
Why?
|
| Intubation, Intratracheal | 3 | 1996 | 1357 | 0.150 |
Why?
|
| Endoscopes | 2 | 1996 | 174 | 0.150 |
Why?
|
| Nasal Septum | 2 | 1988 | 127 | 0.140 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 1998 | 144 | 0.140 |
Why?
|
| Ophthalmoplegia | 1 | 1997 | 166 | 0.130 |
Why?
|
| Cochlea | 3 | 1996 | 828 | 0.120 |
Why?
|
| Lasers | 3 | 1993 | 952 | 0.120 |
Why?
|
| Burkitt Lymphoma | 1 | 1997 | 328 | 0.120 |
Why?
|
| Music | 1 | 1998 | 259 | 0.120 |
Why?
|
| Labyrinthitis | 1 | 1994 | 29 | 0.120 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 1994 | 25 | 0.120 |
Why?
|
| Cochlear Diseases | 1 | 1994 | 23 | 0.120 |
Why?
|
| Holmium | 4 | 1994 | 30 | 0.120 |
Why?
|
| Pharynx | 1 | 1996 | 413 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 5 | 2000 | 2712 | 0.110 |
Why?
|
| Orbital Neoplasms | 2 | 1993 | 225 | 0.100 |
Why?
|
| Microsurgery | 2 | 1996 | 796 | 0.100 |
Why?
|
| Peer Review | 1 | 2013 | 208 | 0.100 |
Why?
|
| Ossification, Heterotopic | 1 | 1994 | 239 | 0.100 |
Why?
|
| Polyps | 1 | 1992 | 189 | 0.100 |
Why?
|
| Airway Resistance | 3 | 2000 | 404 | 0.100 |
Why?
|
| Larynx | 1 | 1996 | 492 | 0.100 |
Why?
|
| Stapes Surgery | 1 | 1991 | 60 | 0.090 |
Why?
|
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 1989 | 4 | 0.090 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1993 | 285 | 0.090 |
Why?
|
| Lipidoses | 1 | 1989 | 10 | 0.090 |
Why?
|
| Hyalin | 1 | 1989 | 37 | 0.090 |
Why?
|
| Tongue | 2 | 1993 | 406 | 0.090 |
Why?
|
| Temporal Bone | 1 | 1994 | 661 | 0.090 |
Why?
|
| Yttrium | 3 | 1994 | 35 | 0.080 |
Why?
|
| Mouth | 1 | 1992 | 373 | 0.080 |
Why?
|
| Documentation | 1 | 2013 | 865 | 0.070 |
Why?
|
| Wound Healing | 3 | 1994 | 2781 | 0.070 |
Why?
|
| Cicatrix | 1 | 1992 | 761 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1996 | 2940 | 0.070 |
Why?
|
| Neck Muscles | 1 | 1986 | 104 | 0.070 |
Why?
|
| Osteotomy | 1 | 1992 | 823 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1993 | 798 | 0.070 |
Why?
|
| Nasal Obstruction | 1 | 1987 | 151 | 0.060 |
Why?
|
| Aluminum Silicates | 2 | 1994 | 26 | 0.060 |
Why?
|
| Nylons | 2 | 1994 | 47 | 0.060 |
Why?
|
| Sinusitis | 1 | 1992 | 922 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 1988 | 663 | 0.060 |
Why?
|
| Palate, Soft | 1 | 2002 | 96 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 1996 | 1799 | 0.050 |
Why?
|
| Lymphatic Metastasis | 3 | 2002 | 2906 | 0.050 |
Why?
|
| Muscles | 1 | 1986 | 1617 | 0.050 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2002 | 347 | 0.050 |
Why?
|
| Skin Diseases | 1 | 1989 | 1065 | 0.050 |
Why?
|
| Body Temperature Regulation | 2 | 1992 | 252 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2013 | 3527 | 0.050 |
Why?
|
| Biopsy | 3 | 2002 | 6756 | 0.040 |
Why?
|
| Radiology | 1 | 2013 | 2090 | 0.040 |
Why?
|
| Snoring | 1 | 2000 | 189 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2002 | 20086 | 0.040 |
Why?
|
| Zygomatic Fractures | 1 | 1998 | 37 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 9185 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2013 | 3738 | 0.040 |
Why?
|
| Glutathione | 1 | 2000 | 586 | 0.040 |
Why?
|
| Rats | 5 | 1997 | 24265 | 0.040 |
Why?
|
| Mitomycin | 2 | 1996 | 259 | 0.040 |
Why?
|
| Male | 23 | 2002 | 349538 | 0.040 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1998 | 204 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1996 | 135 | 0.040 |
Why?
|
| Auditory Threshold | 1 | 1998 | 364 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 1998 | 342 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 2645 | 0.030 |
Why?
|
| S100 Proteins | 1 | 1996 | 259 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 1997 | 8829 | 0.030 |
Why?
|
| Vimentin | 1 | 1996 | 261 | 0.030 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 1995 | 50 | 0.030 |
Why?
|
| Silicones | 2 | 1993 | 248 | 0.030 |
Why?
|
| Bone Plates | 1 | 1998 | 467 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 1993 | 5169 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 1995 | 110 | 0.030 |
Why?
|
| Nose | 2 | 2000 | 509 | 0.030 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 1995 | 96 | 0.030 |
Why?
|
| Glass Ionomer Cements | 1 | 1994 | 17 | 0.030 |
Why?
|
| Cisplatin | 1 | 2000 | 1637 | 0.030 |
Why?
|
| Round Window, Ear | 1 | 1994 | 47 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2002 | 1634 | 0.030 |
Why?
|
| Erbium | 1 | 1993 | 12 | 0.030 |
Why?
|
| Middle Aged | 16 | 2000 | 213127 | 0.030 |
Why?
|
| Polyvinyl Chloride | 1 | 1993 | 34 | 0.030 |
Why?
|
| Humans | 28 | 2002 | 742088 | 0.030 |
Why?
|
| Thermometers | 1 | 1993 | 46 | 0.030 |
Why?
|
| Pulmonary Ventilation | 2 | 2000 | 372 | 0.030 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1993 | 172 | 0.030 |
Why?
|
| Vulvar Neoplasms | 1 | 1995 | 272 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2002 | 35342 | 0.030 |
Why?
|
| Mouth Floor | 1 | 1992 | 34 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1993 | 276 | 0.030 |
Why?
|
| Antioxidants | 1 | 2000 | 1659 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2000 | 941 | 0.030 |
Why?
|
| Nitrous Oxide | 1 | 1993 | 177 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 1994 | 289 | 0.030 |
Why?
|
| Nasal Bone | 1 | 1992 | 58 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1993 | 264 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2002 | 39004 | 0.030 |
Why?
|
| Bone Cements | 1 | 1994 | 325 | 0.030 |
Why?
|
| Fracture Fixation, Internal | 1 | 1998 | 916 | 0.030 |
Why?
|
| Neck Dissection | 1 | 1993 | 196 | 0.030 |
Why?
|
| Keratins | 1 | 1993 | 515 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1998 | 1202 | 0.020 |
Why?
|
| Estrogens | 1 | 1998 | 1562 | 0.020 |
Why?
|
| Stapes | 1 | 1991 | 86 | 0.020 |
Why?
|
| Surgery, Oral | 1 | 1993 | 146 | 0.020 |
Why?
|
| Paranasal Sinuses | 1 | 1993 | 249 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1996 | 1839 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1993 | 579 | 0.020 |
Why?
|
| Nasopharynx | 1 | 1993 | 379 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 1993 | 309 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 1996 | 706 | 0.020 |
Why?
|
| Orbit | 1 | 1993 | 427 | 0.020 |
Why?
|
| Surface Properties | 1 | 1993 | 1182 | 0.020 |
Why?
|
| Desmosomes | 1 | 1989 | 73 | 0.020 |
Why?
|
| Ear, Inner | 1 | 1994 | 420 | 0.020 |
Why?
|
| Deafness | 1 | 1994 | 461 | 0.020 |
Why?
|
| Aged | 12 | 2002 | 162944 | 0.020 |
Why?
|
| Adult | 14 | 2000 | 213712 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 1996 | 8621 | 0.020 |
Why?
|
| Materials Testing | 1 | 1993 | 865 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 1994 | 824 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 1988 | 15244 | 0.020 |
Why?
|
| Postmenopause | 1 | 1998 | 2461 | 0.020 |
Why?
|
| Maxilla | 1 | 1992 | 469 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1996 | 4029 | 0.020 |
Why?
|
| Schwann Cells | 1 | 1989 | 195 | 0.020 |
Why?
|
| Hypopharynx | 2 | 2000 | 52 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 1989 | 279 | 0.020 |
Why?
|
| Epithelium | 1 | 1992 | 1680 | 0.020 |
Why?
|
| Adenoma | 1 | 1998 | 2168 | 0.020 |
Why?
|
| Mandible | 1 | 1992 | 740 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12958 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2002 | 13019 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1993 | 1407 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2000 | 11472 | 0.020 |
Why?
|
| Oxygen | 2 | 2000 | 4169 | 0.020 |
Why?
|
| Animals | 6 | 1997 | 168561 | 0.020 |
Why?
|
| Female | 14 | 2000 | 379592 | 0.020 |
Why?
|
| Time Factors | 3 | 2002 | 40054 | 0.020 |
Why?
|
| Sex Factors | 1 | 1998 | 10392 | 0.010 |
Why?
|
| Prognosis | 2 | 2002 | 29010 | 0.010 |
Why?
|
| Equipment Design | 1 | 1992 | 3582 | 0.010 |
Why?
|
| Endoscopy | 1 | 1993 | 1774 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2002 | 62966 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 5171 | 0.010 |
Why?
|
| Electromyography | 1 | 1986 | 1391 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1993 | 3465 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9305 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1989 | 2968 | 0.010 |
Why?
|
| Palate | 1 | 2000 | 123 | 0.010 |
Why?
|
| Oropharynx | 1 | 2000 | 127 | 0.010 |
Why?
|
| Pilot Projects | 3 | 2000 | 8297 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1998 | 6754 | 0.010 |
Why?
|
| Manometry | 1 | 2000 | 444 | 0.010 |
Why?
|
| Radiotherapy Dosage | 2 | 1996 | 2876 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1998 | 156 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 9144 | 0.010 |
Why?
|
| Oximetry | 1 | 2000 | 467 | 0.010 |
Why?
|
| Polyglycolic Acid | 1 | 1998 | 406 | 0.010 |
Why?
|
| Melanoma | 1 | 1995 | 5462 | 0.010 |
Why?
|
| Skin | 1 | 1989 | 4353 | 0.010 |
Why?
|
| Fracture Healing | 1 | 1998 | 426 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2000 | 1615 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2000 | 53187 | 0.010 |
Why?
|
| Steel | 1 | 1993 | 26 | 0.010 |
Why?
|
| Mitomycins | 1 | 1992 | 47 | 0.010 |
Why?
|
| Lactic Acid | 1 | 1998 | 1132 | 0.010 |
Why?
|
| Aluminum | 1 | 1993 | 152 | 0.010 |
Why?
|
| Plastics | 1 | 1993 | 123 | 0.010 |
Why?
|
| Adolescent | 3 | 1998 | 85649 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1993 | 233 | 0.010 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 1992 | 94 | 0.010 |
Why?
|
| Infrared Rays | 1 | 1993 | 249 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2000 | 12695 | 0.010 |
Why?
|
| Polymers | 1 | 1998 | 1618 | 0.010 |
Why?
|
| Gingiva | 1 | 1993 | 388 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2000 | 2714 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 1992 | 484 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2000 | 4197 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1998 | 1731 | 0.010 |
Why?
|
| Age Distribution | 1 | 1995 | 2900 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 1995 | 1248 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1995 | 1769 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 1995 | 57683 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 10248 | 0.000 |
Why?
|
| Temperature | 1 | 1993 | 2207 | 0.000 |
Why?
|
| Remission Induction | 1 | 1992 | 2384 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 4929 | 0.000 |
Why?
|
| Survival Rate | 1 | 1995 | 12773 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1995 | 11001 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1998 | 21719 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 20928 | 0.000 |
Why?
|
| Risk Factors | 1 | 1998 | 72145 | 0.000 |
Why?
|
| Child | 1 | 1998 | 77478 | 0.000 |
Why?
|
| United States | 1 | 1998 | 69693 | 0.000 |
Why?
|
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_